Anti-Inflammatory and Antiviral Osmotic Polymeric Film to Treat Covid-19 Early-Stage Infection

References

• Binns C, Low WY, Kyung LM. The COVID-19 pandemic: public health and epidemiology. Asia Pac J Public Health. 2020;32:140–144. doi:10.1177/1010539520929223
   PubMed Web of Science ®Google Scholar
• Dawood FS, Ricks P, Njie GJ, et al. Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis. Lancet Infect Dis. 2020;20:1255–1262. doi:10.1016/S1473-3099(20)30581-8
   PubMed Web of Science ®Google Scholar
• Morawska L, Cao J. Airborne transmission of SARS-CoV-2: the world should face the reality. Environ Int. 2020;139:105730. doi:10.1016/j.envint.2020.105730
   PubMed Web of Science ®Google Scholar
• Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA. 2020;117:11727–11734. doi:10.1073/pnas.2003138117
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–280. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Bertram S, Heurich A, Lavender H, et al. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One. 2012;7:e35876. doi:10.1371/journal.pone.0035876
   PubMed Web of Science ®Google Scholar
• Chowdhury MA, Hossain N, Kashem MA, et al. Immune response in COVID-19: a review. J Infect Public Health. 2020;13:1619–1629. doi:10.1016/j.jiph.2020.07.001
   PubMed Web of Science ®Google Scholar
• Torabi A, Mohammadbagheri E, Akbari Dilmaghani N, et al. Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem Neurosci. 2020;11:1909–1913. doi:10.1021/acschemneuro.0c00249
   PubMed Web of Science ®Google Scholar
• Ragab D, Salah Eldin H, Taeimah M, et al. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.01446
   Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–2629. doi:10.1172/JCI137244
   PubMed Web of Science ®Google Scholar
• Bilinska K, Butowt R. Anosmia in COVID-19: a bumpy road to establishing a cellular mechanism. ACS Chem Neurosci. 2020;11:2152–2155. doi:10.1021/acschemneuro.0c00406
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934–943. doi:10.1001/jamainternmed.2020.0994
   PubMed Web of Science ®Google Scholar
• Chen X, Zhao B, Qu Y, et al. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa449
   Web of Science ®Google Scholar
• Zhang C, Wu Z, Li JW, Zhao H, Wang G-Q. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55:105954. doi:10.1016/j.ijantimicag.2020
   PubMed Web of Science ®Google Scholar
• Shimabukuro-Vornhagen A, Gödel P, Subklewe M, et al. Cytokine release syndrome. J Immunother Cancer. 2018;6:56. doi:10.1186/s40425-018-0343-9
   PubMed Web of Science ®Google Scholar
• Mason RJ. Pathogenesis of COVID-19 from a cell biologic perspective. Eur Respir J. 2020;55:2000607. doi:10.1183/13993003.00607-2020
   PubMed Web of Science ®Google Scholar
• Sivabakya TK, Srinivas G. Lung barrier function in COVID-19? SN Compr Clin Med. 2020;2:1299–1301. doi:10.1007/s42399-020-00427-5
   PubMedGoogle Scholar
• Sabino EC, Buss LF, Carvalho MPS, et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet. 2021;397:452–455. doi:10.1016/S0140-6736(21)00183-5
   PubMed Web of Science ®Google Scholar
• Roguet R, Cohen C, Dossou KG, et al. Episkin, a reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds. Toxicol in vitro. 1994;8:283–291.
   PubMed Web of Science ®Google Scholar
• Shrivastava R, Delomenie C, Chevalier A, et al. Comparison of in vivo acute lethal potency and in vitro cytotoxicity of 48 chemicals. Cell Biol Toxicol. 1992;8:157–170. doi:10.1007/BF00260565
   PubMed Web of Science ®Google Scholar
• Shrivastava R. In vitro tests in pharmacotoxicology: can we fill the gap between scientific advances and industrial needs? Altern Lab Anim. 2020. doi:10.1177/026119299702500315
   Google Scholar
• Shrivastava R, Shrivastava L, Shrivastava RM. Composition for topical application comprising glycerol and tannins PCT. Patent/WO/20141/194966. 2017. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2014194966. 2021 Mar 19.
   Google Scholar
• Riss T, Moravec R, Niles AD. S. Cell viability assays - assay guidance manual - NCBI bookshelf; 2016. Available from: https://www.ncbi.nlm.nih.gov/books/NBK144065/. Accessed October 14, 2020.
   Google Scholar
• Fischer AH, Jacobson KA, Rose J, et al. Hematoxylin and Eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008;2008:pdb.prot4986-pdb.prot4986. doi:10.1101/pdb.prot4986
   Google Scholar
• Schrage A, Kolle SN, Moreno MCR, et al. Bovine corneal opacity and permeability test in routine ocular irritation testing and its improvement within the limits of OECD test guideline 437. Altern Lab Anim. 2011;39:37–53. doi:10.1177/026119291103900119
   PubMed Web of Science ®Google Scholar
• Smith AAA, Kryger MBL, Wohl BM, et al. Macromolecular (pro)drugs in antiviral research. Polym Chem. 2014;5:6407–6425. doi:10.1039/C4PY00624K
   Web of Science ®Google Scholar
• Zhang QW, Lin LG, Ye WC. Techniques for extraction and isolation of natural products: a comprehensive review; 2018. Available from: https://pubmed.ncbi.nlm.nih.gov/29692864/. Accessed October 14, 2020.
   Google Scholar
• Neufurth M, Wang X, Tolba E, et al. The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations. Biochem Pharmacol. 2020;182:114–215. doi:10.1016/j.bcp.2020.114215
   Web of Science ®Google Scholar
• Kritas SK, Ronconi G, Caraffa A, et al. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. J Biol Regul Homeost Agents. 2020;34(1):9–14. doi:10.23812/20-Editorial-Kritas
   PubMed Web of Science ®Google Scholar
• Conti P, Caraffa A, Gallenga CE, et al. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra). J Biol Regul Homeost Agents. 2020;34(5):1623–1627. doi:10.23812/20-34-4EDIT-65
   PubMed Web of Science ®Google Scholar
• Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents. 2020;34(2):327–331. doi:10.23812/CONTI-E
   PubMed Web of Science ®Google Scholar
• Conti P, Gallenga CE, Tetè G, et al. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020;34(2):333–338. doi:10.23812/Editorial-Conti-2
   PubMed Web of Science ®Google Scholar
• Batah SS, Fabro AT. Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians. Respir Med. 2020;176:106239. doi:10.1016/j.rmed.2020.106239
   PubMed Web of Science ®Google Scholar
• Shrivastava R, Shrivastava C. New synergistic compositions for the treatment of topical viral infections. PCT Patent WO2011082835A1. 2011. https://patents.google.com/patent/WO2011082835A1/en. 2021 Mar 19.
   Google Scholar
• Shrivastava R, Shrivastava L, Shrivastava R. Dual acting polymers in an osmotic film for topical application to treat inflammatory diseases and cytokine release syndrome. PCT Patent Pending N° R36575WO. 2020 Sept 08.
   Google Scholar